ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
434K |
0 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
1.3K
|
434K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
13K |
6.5M |
3 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
13K
|
6.5M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
1
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Names Robin VanDenburgh as SVP of Sales
|
|
whytee
|
26 |
7.5K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
26
|
7.5K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
3 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
2 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
1 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
385
|
184K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
434K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
1.3K
|
434K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
13K |
6.5M |
7 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
13K
|
6.5M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Names Robin VanDenburgh as SVP of Sales
|
|
whytee
|
26 |
7.5K |
0 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
26
|
7.5K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
whytee
|
13K |
6.5M |
5 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
13K
|
6.5M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
385
|
184K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
385
|
184K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
385
|
184K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.3K |
1.4M |
5 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
3.3K
|
1.4M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
whytee
|
12K |
4.0M |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
12K
|
4.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
whytee
|
12K |
4.0M |
1 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
12K
|
4.0M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
1 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
385
|
184K
|
1
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.3K |
1.4M |
11 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
3.3K
|
1.4M
|
11
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
353 |
93K |
1 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
353
|
93K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
0 |
04/08/24 |
04/08/24 |
ASX - By Stock
|
385
|
184K
|
0
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
353 |
93K |
4 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
353
|
93K
|
4
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
353 |
93K |
6 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
353
|
93K
|
6
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
353 |
93K |
2 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
353
|
93K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
whytee
|
385 |
184K |
2 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
385
|
184K
|
2
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
353 |
93K |
3 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
353
|
93K
|
3
|
|
ASX - By Stock
|
OPT |
Re:
Ann: Security Class Reinstatement to Quotation- OPTOB
|
|
whytee
|
353 |
93K |
4 |
03/08/24 |
03/08/24 |
ASX - By Stock
|
353
|
93K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.3K |
1.4M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.3K
|
1.4M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
whytee
|
18K |
7.2M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
18K
|
7.2M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.3K |
1.4M |
7 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.3K
|
1.4M
|
7
|
|
ASX - By Stock
|
AVH |
Re:
Ann: AVITA Medical Expands Portfolio with Unique Dermal Matrix
|
|
whytee
|
47 |
15K |
1 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
47
|
15K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Pick Today's Price Range Low-High... Just for Fun
|
|
whytee
|
1.3K |
434K |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
1.3K
|
434K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.3K |
1.4M |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.3K
|
1.4M
|
6
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.8K |
9 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.8K
|
9
|
|
ASX - By Stock
|
PNV |
Re:
PNV Media Thread
|
|
whytee
|
3.3K |
1.4M |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
3.3K
|
1.4M
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.8K |
10 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.8K
|
10
|
|
ASX - By Stock
|
OIL |
Re:
Leeds has become the UK Reference Centre for Convivo
|
|
whytee
|
6 |
1.8K |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6
|
1.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
6.1K |
3.0M |
0 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6.1K
|
3.0M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
MESO Nasdaq update
|
|
whytee
|
6.1K |
3.0M |
3 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
6.1K
|
3.0M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
2 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
10K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Back pain trial
|
|
whytee
|
35 |
10K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
35
|
10K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
whytee
|
132 |
44K |
0 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
132
|
44K
|
0
|
|